Induction and antimicrobial activity of platelet basic protein derivatives in human monocytes

Journal of Leukocyte Biology

Volumn 76, Issue 5, 2004, Pages 1010-1018

  Schaffner, Andreas ^a,c   King, Charles C ^b   Schaer, Dominik ^c   Guiney, Donald G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c Medizinische Klinik Zurich   (Switzerland)

Author keywords

thromboglobulin; Antimicrobial cationic peptides; Chemokines; Macrophages; Proteinase activated; Receptors

Indexed keywords

BETA THROMBOGLOBULIN; CELL PROTEIN; CHEMOKINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCLONAL ANTIBODY; PLATELET BASIC PROTEIN ANTIBODY; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; THROMBOCYTE ANTIBODY; THROMBOCYTE BASIC PROTEIN; UNCLASSIFIED DRUG; ZYMOSAN;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FLOTATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; IONIZATION; LASER; LYSOSOME; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MONOCYTE; PHAGOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; WESTERN BLOTTING;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; BETA-THROMBOGLOBULIN; CELL LINE; CHEMOKINES; GENE EXPRESSION REGULATION; HUMANS; LIPOPOLYSACCHARIDES; MONOCYTES; PEPTIDE FRAGMENTS; PEPTIDES; PHAGOSOMES; RECEPTORS, PROTEINASE-ACTIVATED; RNA, MESSENGER; THROMBIN; UP-REGULATION; ZYMOSAN;

RICKETTSIA SP. PAR;

EID: 7644221443     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0404261     Document Type: Article

References (56)

1. Dimarcq, J. L., Bulet, P., Hetru, C., Hoffmann, J. (1998) Cysteine-rich antimicrobial peptides in invertebrates. Biopolymers 47, 465-477.
2. Gallo, R. L., Nizet, V. (2003) Endogenous production of antimicrobial peptides in innate immunity and human disease. Curr. Allergy Asthma Rep. 3, 402-409.
3. Ganz, T., Weiss, J. (1997) Antimicrobial peptides of phagocytes and epithelia. Semin. Hematol. 34, 343-354.
4. Ganz, T., Lehrer, R. I. (1998) Antimicrobial peptides of vertebrates. Curr. Opin. Immunol. 10, 41-44.
5. Ganz, T. (2003) Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710-720.
6. Lehrer, R. I., Ganz, T. (2002) Defensins of vertebrate animals. Curr. Opin. Immunol. 14, 96-102.
7. Lehrer, R. I., Ganz, T. (1999) Antimicrobial peptides in mammalian and insect host defense. Curr. Opin. Immunol. 11, 23-27.
8. Lehrer, R. I., Ganz, T. (2002) Cathelicidins: a family of endogenous antimicrobial peptides. Curr. Opin. Hematol. 9, 18-22.
9. Lehrer, R. I., Szklarek, D., Selsted, M. E., Fleischmann, J. (1981) Increased content of microbicidal cationic peptides in rabbit alveolar macrophages elicited by complete Freund adjuvant. Infect. Immun. 33, 775-778.
10. Oppenheim, J. J., Biragyn, A., Kwak, L. W., Yang, D. (2003) Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann. Rheum. Dis. 62 (Suppl. 2), ii17-ii21.
11. Yang, D., Chertov, O., Oppenheim, J. J. (2001) The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity. Cell. Mol. Life Sci. 58, 978-989.
12. Yang, D., Chen, Q., Hoover, D. M., Staley, P., Tucker, K. D., Lubkowski, J., Oppenheim, J. J. (2003) Many chemokines including CCL20/MIP-3α display antimicrobial activity. J. Leukoc. Biol. 74, 448-455.
13. Yeaman, M. R., Bayer, A. S. (1999) Antimicrobial peptides from platelets. Drug Resist. Updat. 2, 116-126.
14. Miyata, T., Tokunaga, F., Yoneya, T., Yoshikawa, K., Iwanaga, S., Niwa, M., Takao, T., Shimonishi, Y. (1989) Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity. J. Biochem. (Tokyo) 106, 663-668.
15. Kairies, N., Beisel, H. G., Fuentes-Prior, P., Tsuda, R., Muta, T., Iwanaga, S., Bode, W., Huber, R., Kawabata, S. (2001) The 2.0-A crystal structure of tachylectin 5A provides evidence for the common origin of the innate immunity and the blood coagulation systems. Proc. Natl. Acad. Sci. USA 98, 13519-13524.
16. Lehrer, R. I., Ganz, T. (1996) Endogenous vertebrate antibiotics. Defensins, protegrins, and other cysteine-rich antimicrobial peptides. Ann. N. Y. Acad. Sci. 797, 228-239.
17. Secombes, C. J., Bird, S., Hong, S., Laing, K. J., Zou, J. (2001) Phylogeny of vertebrate cytokines. Adv. Exp. Med. Biol. 484, 89-94.
18. Secombes, C. J., Wang, T., Hong, S., Peddie, S., Crampe, M., Laing, K. J., Cunningham, C., Zou, J. (2001) Cytokines and innate immunity of fish. Dev. Comp. Immunol. 25, 713-723.
19. Yang, D., Biragyn, A., Kwak, L. W., Oppenheim, J. J. (2002) Mammalian defensins in immunity: more than just miorobioidal. Trends Immunol. 23, 291-296.
20. Ganz, T., Lehrer, R. I. (1997) Antimicrobial peptides of leukocytes. Curr. Opin. Hematol. 4, 53-58.
21. Ganz, T., Selsted, M. E., Lehrer, R. I. (1990) Defensins. Eur. J. Haematol. 44, 1-8.
22. Kokryakov, V. N., Harwig, S. S. L., Panyutich, E. A., Shevchenko, A. A., Aleshina, G. M., Shamova, O. V., Korneva, H. A., Lehrer, R. I. (1993) Protegrins-leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett. 327, 231-236.
23. Zanetti, M. (2004) Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75, 39-48.
24. Selsted, M. E., Ouellette, A. J. (1995) Defensins in granules of phagocytic and non-phagocytic cells. Trends Cell Biol. 5, 114-119.
25. Tang, Y. Q., Yuan, J., Osapay, G., Osapay, K., Tran, D., Miller, C. J., Ouellette, A. J., Selsted, M. E. (1999) A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated α-defensins. Science 286, 498-502.
26. El-Gedaily, A., Schoedon, G., Schneemann, M., Schaffner, A. (2004) Constitutive and regulated expression of platelet basic protein in human monocytes. J. Leukoc. Biol. 75, 495-503.
27. Durr, M., Peschel, A. (2002) Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect. Immun. 70, 6515-6517.
28. Cole, A. M., Ganz, T., Liese, A. M., Burdick, M. D., Liu, L., Stricter, R. M. (2001) Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J. Immunol. 167, 623-627.
29. Varma, K. G., Niewiarowski, S., Holt, J. C., Rucinski, B., Paul, D. (1982) Human platelet basic protein. Its relation to low affinity platelet factor 4 and β-thromboglobulin. Biochim. Biophys. Acta 701, 7-11.
30. Walz, A., Dewald, B., von Tsoharner, V., Baggiolini, M. (1989) Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils. J. Exp. Med. 170, 1745-1750
31. Walz, A., Baggiolini, M. (1990) Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases. J. Exp. Med. 171, 449-454.
32. Zhang, C., Thornton, M. A., Kowalska, M. A., Sachis, B. S., Feldman, M., Poncz, M., McKenzie, S. E., Reilly, M. P. (2001) Localization of distal regulatory domains in the megakaryocyte-specific platelet basic protein/platelet factor 4 gene locus. Blood 98, 610-617.
33. Martins-Green, M., Hanafusa, H. (1997) The 9E3/CEF4 gene and its product the chicken chemotactic and angiogenic factor (cCAF): potential roles in wound healing and tumor development. Cytokine Growth Factor Rev. 8, 221-232.
34. Vaingankar, S. M., Martins-Green, M. (1998) Thrombin aivation of the 9E3/CEF4 chemokine involves tyrosine kinases including c-src and the epidermal growth factor receptor. J. Biol. Chem. 273, 5226-5234.
35. Colognato, R., Slupsky, J. R., Jendrach, M., Burysek, L., Syrovets, T., Simmet, T. (2003) Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells. Blood 2002-2008.
36. Schaffner, A., Rellstab, P. (1988) γ-Interferon restores listericidal activity and concurrently enhances release of reactive oxygen metabolites in dexamethasone-treated human monocytes. J. Clin. Invest. 82, 913-919.
37. Libby, S. J., Lesnick, M., Hasegawa, P., Weidenhammer, E., Guiney, D. G. (2000) The Salmonella virulence plasmid spv genes are required for cytopathology in human monocyte-derived macrophages. Cell. Microbiol. 2, 49-58.
38. Valdivia, R. H., Falkow, S. (1997) Fluorescence-based isolation of bacterial genes expressed within host cells. Science 277, 2007-2011.
39. Fields, P. I., Swanson, R. V., Haidaris, C. G., Heffron, F. (1986) Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc. Natl. Acad. Sci. USA 83, 5189-5193.
40. Desjardins, M., Celis, J. E., van Meer, G., Dieplinger, H., Jahraus, A., Griffiths, G., Huber, L. A. (1994) Molecular characterization of phagosomes. J. Biol. Chem. 269, 32194-32200.
41. Desjardins, M., Huber, L. A., Parton, R. G., Griffiths, G. (1994) Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. J. Cell Biol. 124, 677-688.
42. Lehrer, R. I., Rosenman, M., Harwig, S. S., Jackson, R., Eisenhauer, P. (1991) Ultrasensitive assays for endogenous antimicrobial polypeptides. J. Immunol. Methods 137, 167-173.
43. Garvis, S. G., Beuzon, C. R., Holden, D. W. (2001) A role for the PhoP/Q regulon in inhibition of fusion between lysosomes and Salmonella-containing vacuoles in macrophages. Cell. Microbiol. 3, 731-744.
44. Hollenberg, M. D., Compton, S. J. (2002) International Union of Pharmacology. XXVIII. proteinase-activated receptors. Pharmacol. Rev. 54, 203-217.
45. Li, Q. J., Vaingankar, S., Sladek, F. M., Martins-Green, M. (2000) Novel nuclear target for thrombin: activation of the Elk1 transcription factor leads to chemokine gene expression. Blood 96, 3696-3706.
46. Li, Q. J., Yang, S. H., Maeda, Y., Sladek, F. M., Sharrocks, A. D., Martins-Green, M. (2003) MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300. EMBO J. 22, 281-291.
47. Ernst, R. K., Guina, T., Miller, S. I. (1999) How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. J. Infect. Dis. 179 (Suppl. 2), S326-S330.
48. Car, B. D., Baggiolini, M., Walz, A. (1991) Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue- activating peptide III by different tissue proteinases. Biochem. J. 275, 581-584.
49. Tang, Y. Q., Yeaman, M. R., Selsted, M. E. (2002) Antimicrobial peptides from human platelets. Infect. Immun. 70, 6524-6533.
50. Hollenberg, M. D. (2003) Proteinase-mediated signaling: proteinase-activated receptors (PARs) and much more. Life Sci. 74, 237-246.
51. Iwanaga, S., Kawabata, S. (1998) Evolution and phylogeny of defense molecules associated with innate immunity in horseshoe crab. Front. Biosci. 3, D973-D984.
52. Opal, S. M. (2000) Phylogenetic and functional relationships between coagulation and the innate immune response. Crit. Care Med. 28, S77-S80.
53. Deutsch, V., Bitan, M., Friedmann, Y., Eldor, A., Vlodavsky, I. (2000) Megakaryocyte maturation is associated with expression of the CXC chemokine connective tissue-activating peptide CTAP III. Br. J. Haematol. 111, 1180-1189.
54. Psuja, P., Zozulinska, M., Turowiecka, Z., Cieslikowski, W., Vinazzer, H., Zawilska, K. (2002) Plasma markers of hypercoagulability in patients with serious infections and risk of septic shock. Clin. Appl. Thromb. Hemost. 8, 225-230.
55. Ungerstedt, J. S., Soop, A., Sollevi, A., Blomback, M. (2003) Bedside monitoring of coagulation activation after challenging healthy volunteers with intravenous endotoxin. Thromb. Res. 111, 329-334.
56. van der Poll, T., Buller, H. R., ten Cate, H., Wortel, C. H., Bauer, K. A., van Deventer, S. J., Hack, C. E., Sauerwein, H. P., Rosenberg, R. D., ten Cate, J. W. (1990) Activation of coagulation after administration of tumor necrosis factor to normal subjects. N. Engl. J. Med. 322, 1622-1627.